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Cathepsin L peptidases 
A B S T R A C T   
Fasciolosis, a global parasitic disease of agricultural livestock, is caused by the liver fluke Fasciola hepatica. 
Management and strategic control of fasciolosis on farms depends on early assessment of the extent of disease so 
that control measures can be implemented quickly. Traditionally, this has relied on the detection of eggs in the 
faeces of animals, a laborious method that lacks sensitivity, especially for sub-clinical infections, and identifies 
chronic infections only. Enzyme linked immunosorbent assays (ELISA) offer a quicker and more sensitive 
serological means of diagnosis that could detect early acute infection before significant liver damage occurs. The 
performance of three functionally-active recombinant forms of the major F. hepatica secreted cathepsins L, 
rFhCL1, rFhCL2, rFhCL3, and a cathepsin B, rFhCB3, were evaluated as antigens in an indirect ELISA to sero-
logically diagnose liver fluke infection in experimentally and naturally infected sheep. rFhCL1 and rFhCL3 were 
the most effective of the four antigens detecting fasciolosis in sheep as early as three weeks after experimental 
infection, at least five weeks earlier than both coproantigen and faecal egg tests. In addition, the rFhCL1 and 
rFhCL3 ELISAs had a very low detection limit for liver fluke in lambs exposed to natural infection on pastures and 
thus could play a major role in the surveillance of farms and a ‘test and treat’ approach to disease management. 
Finally, antibodies to all three cathepsin L proteases remain high throughout chronic infection but decline 
rapidly after drug treatment with the flukicide, triclabendazole, implying that the test may be adapted to trace 
the effectiveness of drug treatment.   
1. Introduction 
Fasciolosis, also known as liver fluke disease, is caused by trematodes 
of the genus Fasciola. F. hepatica has one of the greatest geographical 
distributions for parasites infecting livestock and causes enormous losses 
to the global agricultural sector (Charlier et al., 2020). Infection is ac-
quired when livestock ingest infective encysted metacercariae that have 
emerged from the intermediate host, the mud snail Galba truncatula, and 
settled on grass. After excystment in the intestine, the parasite pene-
trates the intestinal wall and migrates to the liver, after which the dis-
ease progresses in two clinical phases. Acute fasciolosis begins within 
approximately two weeks of infection and results from tissue damage 
and haemorrhaging caused by the parasites’ tunnelling and feeding 
activity in the liver tissue, and as a result of the immunopathology 
associated with the host’s immune responses. Then, after 8–12 weeks 
the chronic phase begins when the flukes migrate into the bile ducts, 
where they mature and produce eggs. The chronic phase can last for 
months and even years if untreated. 
The extent of clinical pathology depends on the host, specifically 
their breed, condition, nutritional status and, most importantly, the 
burden of infection (Chauvin et al., 2001). In general, infections in sheep 
tend to be more severe than in cattle due to their apparent lack of 
resistance to the parasite. While acute infections with large numbers of 
parasites that penetrate the liver within a short period of time can cause 
extensive damage to the liver and sudden death in sheep, trickle in-
fections over weeks or months are considered more typical and, 
* Corresponding author at: School of Natural Sciences, National University of Ireland Galway, Galway, Ireland. 
E-mail address: krystyna.cwiklinski@nuigalway.ie (K. Cwiklinski).  
Contents lists available at ScienceDirect 
Veterinary Parasitology 
journal homepage: www.elsevier.com/locate/vetpar 
https://doi.org/10.1016/j.vetpar.2021.109517 
Received 7 May 2021; Received in revised form 29 June 2021; Accepted 3 July 2021   
Veterinary Parasitology 298 (2021) 109517
2
therefore, acute and chronic infection can occur simultaneously. The 
most common form of fasciolosis on sheep farms is sub-clinical with low 
burdens of liver fluke; nevertheless, these can reduce weight gain, wool 
quality (Hayward et al., 2021) and increase the susceptibility of sheep to 
other infections (Munita et al., 2019b). 
Management of fasciolosis on sheep farms depends on predicting the 
extent of infection early so that the appropriate anthelminthic in-
terventions can be applied to prevent losses without the risk of over- 
treatment and the possibility of abetting the development of drug 
resistance in parasites (Kelley et al., 2016; Kamaludeen et al., 2019; 
Fairweather et al., 2020). Therefore, a diagnostic that can accurately 
detect the early onset of infection is imperative so that a targeted 
treatment programme can be employed. Traditionally, diagnosis relies 
on the identification of liver fluke eggs in faecal samples (faecal egg 
count, FEC), but this method is not only time-consuming and laborious, 
it is also insensitive, especially in the case of low parasite burdens. In 
addition, the method detects infection only after the parasites have 
matured and produced eggs within the bile ducts, well after liver dam-
age has ensued. Accordingly, recent approaches have employed immu-
nological techniques to improve the sensitivity and accuracy of fluke 
detection in sheep and cattle, for example, the use of capture enzyme 
linked immunosorbent assays (ELISA) for the detection of liver fluke 
coproantigens in faeces (Martínez-Sernández et al., 2016) and serolog-
ical ELISA for the detection of anti-fluke antibodies in blood samples 
(Cornelissen et al., 2001; Salimi-Bejestani et al., 2005; Mezo et al., 2007; 
reviewed by Alvarez Rojas et al., 2014). 
Research in our laboratory has shown that as the liver flukes migrate 
through the tissues of its host they release a variety of proteolytic en-
zymes which assist in the breakdown of host tissue, the formation of the 
migratory path, blood feeding and immunomodulation (Cwiklinski 
et al., 2019). These cathepsin-like cysteine peptidases are produced by 
the gastrodermal cells of the parasite gut and are strictly 
developmentally-regulated (Cwiklinski et al., 2019); thus, the predom-
inant proteases released by adult flukes in the bile ducts are the 
cathepsin L peptidases termed FhCL1 and FhCL2 while those released by 
the juvenile flukes that penetrate the intestine are the cathepsin L, 
FhCL3, and three cathepsins B, FhCB1, 2 and 3. FhCL1 is the best 
characterised of these enzymes, biochemically and structurally (Smith 
et al., 1993; Dowd et al., 1994; Collins et al., 2004; Stack et al., 2008), 
and has been shown by us and several other laboratories to be highly 
immunogenic and, therefore, useful in the serological detection of fas-
ciolosis in animals and humans (O’Neill et al., 1998; Strauss et al., 1999; 
Cornelissen et al., 2001; Salimi-Bejestani et al., 2005; Gonzales Santana 
et al., 2013; Sugiyama et al., 2021). 
In this study, we evaluated the performance of the most highly 
expressed members of the F. hepatica cysteine peptidases, namely 
FhCL1, FhCL2, FhCL3 and FhCB3, to detect liver fluke infection in 
experimentally- and naturally-infected lambs. The aim of the study was 
to assess whether these assays were applicable for evaluating lambs put 
on pasture that act as sentinels for fluke prevalence, that could play a 
valuable role in the ‘test and treat’ approach to liver fluke control and 
management. Antibody levels following drug treatment with the fluki-
cide, triclabendazole (TCBZ) were analysed to trace the effectiveness of 
drug treatment and the effects on anti-Fasciola responses. 
2. Materials and methods 
2.1. Ethical statement 
Experimental procedures at Moredun Scientific, UK were carried out 
under license from the UK Home Office by the Animal (Scientific Pro-
cedures) Act 1986 (License No. PPL/60/4426) after ethical review by 
the Moredun Scientific Animal Ethics Committee. Euthanasia of animals 
at Moredun Scientific was carried out by lethal injection. Experimental 
procedures at Agri-Food and Biosciences Institute (AFBI; UK) were 
carried out under license from the Department of Health, Social Services 
and Public by the Animal (Scientific Procedures) Act 1986 (License No. 
PPL 2771; PPL 2801), after ethical review by the AFBI Animal Ethics 
Committee. Experimental procedures at Teagasc Athenry (Ireland) were 
carried out under license from Health Products Regulatory Authority 
(HPRA) by the EU Directive 2010/63/EU (License No. AE19132/P097), 
after ethical review by the Teagasc Animal Ethics Committee. Eutha-
nasia of animals at AFBI and Teagasc sites was carried out by captive 
bolt. 
2.2. Experimental and field infections of sheep 
Trial 1 (Moredun 1): Fourteen eight-month-old Texel cross sheep 
(UK; male n = 2; female n = 12) were orally infected with 150 F. hepatica 
metacercariae (South Gloucester isolate: Ridgeway Research Ltd). Blood 
samples were collected by jugular venepuncture prior to infection, at 
three weeks post infection (wpi) and on the day of necropsy, at 16 wpi. 
At necropsy, total enumeration of fluke burden was carried out on 
parasites recovered from the liver parenchyma and bile ducts (as per 
protocols used by Hodgkinson et al., 2018). 
Trial 2 (AFBI 1): Eighteen six-month-old male Dorset cross sheep 
(UK) were orally infected with 150 F. hepatica metacercariae (Italian 
isolate: Ridgeway Research Ltd). Blood samples were collected by ju-
gular venepuncture on the day of infection and the day of necropsy, 
which occurred on 2 days post infection (dpi; n = 6), 9 dpi (n = 6) and 18 
dpi (n = 6). At necropsy on 18 dpi, the visceral and diaphragmatic as-
pects of the liver were photographed for gross evaluation to evaluate 
infection. 
Trial 3 (AFBI 2): Sixteen six-month-old Dorset cross sheep (UK; male 
n = 8; female n = 8) were orally infected with 150 F. hepatica meta-
cercariae (South Gloucester isolate: Ridgeway Research Ltd). Blood 
samples were collected by jugular venepuncture on the day of infection, 
at three wpi and at necropsy, at 16 wpi. At necropsy, total enumeration 
of fluke burden carried was out on parasites recovered from the liver 
parenchyma and bile ducts. 
Trial 4 (AFBI 3): Sixteen six-month-old male Dorset cross sheep (UK) 
were orally infected with 120 F. hepatica metacercariae (Italian isolate: 
Ridgeway Research Ltd). Blood samples were collected by jugular ven-
epuncture on the day of infection and at 3, 7, 11, 15, 20, 21, 23, 24 and 
25 wpi. At 17 wpi, six animals were treated with one dose of TCBZ, 
following the dosage rates recommended by the manufacturer (Fasinex 
5%; 1 mL per 5 kg; Triclabendazole 5.00 % w/v). At necropsy (25 wpi), 
total enumeration of fluke burden was carried out on parasites recovered 
from the liver parenchyma and bile ducts. 
Trial 5 (Moredun 2): Thirteen eight-month-old male Texel cross 
sheep (UK) were orally infected with 120 F. hepatica metacercariae 
(Italian isolate: Ridgeway Research Ltd). Blood samples were collected 
by jugular venepuncture on the day of infection, at three wpi and at 
necropsy, 16 wpi. At necropsy, total enumeration of fluke burden was 
carried out on parasites recovered from the liver parenchyma and bile 
ducts. 
Trial 6 (Teagasc): Twenty six-month-old sheep of three breeds 
(Texel, Suffolk and Belclare; Ireland; male n = 9, female n = 11) were 
put onto F. hepatica-contaminated pasture for eight weeks, after which 
the animals were housed for a further seven weeks prior to necropsy. 
Blood samples were collected by jugular venepuncture at the start of the 
study and at 4, 9 and 15 weeks post-liver fluke exposure (wpe). Rectal 
faecal samples were collected for analysis by faecal egg count (FEC) and 
coproantigen-ELISA at 9, 11, 13 and 15 wpe. At necropsy (15 wpe), total 
enumeration of fluke burden was carried out on parasites recovered 
from the liver parenchyma and bile ducts. 
2.3. Recombinant protein production 
F. hepatica cathepsin L (FhCL1, FhCL2, FhCL3) and cathepsin B 
(FhCB3) cysteine peptidases were expressed as functionally active re-
combinant forms in the methylotrophic yeast Pichia pastoris as 
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previously described by Collins et al. (2004). Soluble recombinant 
proteins secreted into the culture supernatant were purified and buffer 
exchanged into phosphate buffered saline (PBS, pH 7.4) using 
Nickle-chelate affinity chromatography. Protein concentration and pu-
rity were verified by Bradford Protein Assay (Bio-Rad) and by 4–20 % 
SDS-PAGE gels (Bio-Rad) stained with Biosafe Coomassie (Bio-Rad), 
respectively. The gels were visualised using a G:BOX Chemi XRQ imager 
(Syngene). 
2.4. Analysis of anti-F. hepatica cathepsin-specific antibodies in sheep 
sera samples by ELISA 
Flat-bottom 96 well microtitre plates (Nunc™ Maxisorp ™, Ther-
moFisher Scientific) were coated in triplicate with 100 μL of 1 μg/mL of 
the recombinant antigens (rFhCL1, rFhCL2, rFhCL3 or rFhCB3) in 0.05 
M carbonate buffer, pH 9.6, and incubated overnight at 4 ◦C. After three 
washes with 100 μL of PBS-0.05 % Tween 20 (PBST), 100 μL/well of 
blocking buffer (2% bovine serum albumin diluted in PBST) was added 
and incubated for 1 h at 37 ◦C, with shaking at 160 rpm. After washing 
three times with PBST, 100 μL of serum samples from sheep diluted 
1:100 in serum dilution buffer (PBS, 0.5 % Tween 80, 0.5 M NaCl) were 
added and the plates were incubated 1 h at 37 ◦C with shaking at 160 
rpm. After washing five times, 100 μL/well of HRP-conjugated donkey 
anti-sheep IgG (ThermoFisher Scientific), diluted 1:50,000 in blocking 
buffer, was added and the plates were incubated for 1 h at 37 ◦C, with 
shaking at 160 rpm. Following five washes, 100 μL/well of 3,3′,5,5′- 
Tetramethylbenzidine (TMB; Sigma-Aldrich) was added and the plates 
incubated at room temperature for 4 min. The reaction was stopped by 
the addition of 100 μL/well of 1 M sulphuric acid. The optical density 
was determined at a wavelength of 450 nm (OD450) in a PolarStar 
Omega spectrophotometer (BMG LabTech). For the analysis of the three 
week time-point from trials 1, 3, 4 and 5, a cut-off point was calculated 
based on the mean optical density plus 3.09 standard deviations (SD, as 
per Valero et al., 2012; Devanarayan et al., 2017) of the negative 
animals. 
2.5. Coproantigen-ELISA 
F. hepatica-specific antigen in the faecal samples from sheep in Trial 6 
were detected using the commercially available F. hepatica 
coproantigen-ELISA kit BIO K 201/2 (Bio-X Diagnostics; Martí-
nez-Sernández et al., 2016), according to the manufacturer’s in-
structions for sheep samples. All faecal samples were weighed out on the 
day of collection (0.5 g per animal) and stored overnight at 4 ◦C prior to 
processing. Positive samples were determined by expressing their net 
optical density as a percentage and comparing it with the provided 
cut-off as indicated in the kit instructions. 
2.6. Faecal egg count (FEC) 
FEC were performed on 5 g of faeces per animal within two weeks of 
collection. Faecal samples were homogenised in water prior to sieving 
through 710, 150 and 38 μm stainless steel Endecott sieves (200 Mm 
diameter) in sequence. The sediment retained on the 38 μm sieve were 
back-washed into a glass beaker and diluted to a volume of 500 mL with 
water. The suspension was left for 4 min to allow sedimentation of the 
F. hepatica eggs, after which the supernatant was decanted and the 
sediment re-suspended in 500 mL of water. This process was repeated 
until the supernatant was clear. The final sediment was re-suspended in 
75 mL of water to which 1 % (w/v) methylene blue was added before it 
was transferred to a petri dish for microscopy at 40x magnification using 
a Kyowa Optical stereo microscope (SDZ-PL). 
2.7. Statistical analyses 
Statistical analyses were carried out using GraphPad Prism version 5. 
Two-way ANOVA including Bonferroni post-tests were performed to 
determine the significance of the differences between levels of total IgG 
in serum samples detected using every antigen (values were significant if 
P < 0.05). Correlation analyses were carried out following a nonpara-
metric correlation approach to calculate the Spearman r. 
3. Results 
3.1. Comparison of recombinant cathepsin antigens for use in serological 
test for fasciolosis 
Recombinant expression of three F. hepatica cathepsin L peptidases, 
FhCL1, FhCL2, and FhCL3, and a cathepsin B peptidase (FhCB3) was 
carried out using the P. pastoris yeast expression system. Proteins were 
purified from the yeast culture supernatant by one-step Nickle-chelate 
affinity chromatography which resulted in high yields ranging from four 
to ten mg protein per litre of culture medium. All four recombinant 
proteins were analysed by SDS-PAGE and were shown to migrate as 
single bands at the expected molecular weight (~37 kDa) and be of high 
purity (Fig. 1). Furthermore, all four proteins were demonstrated to be 
functionally active using fluorogenic peptide substrates (as per De 
Marco Verissimo et al., 2020) and, hence, structurally folded in native 
form. 
Using an ELISA-based assay, the efficacy of the four recombinant 
cathepsin peptidases for serodiagnosis of fasciolosis was evaluated. The 
primary and secondary antibodies were titrated before defining optimal 
dilutions of 1:100 for the primary antibody and 1:50,000 for the sec-
ondary HRP-conjugated donkey anti-sheep IgG. Using these conditions, 
antibodies present in serum collected at three and 16 wpi from seven 
animals experimentally infected with F. hepatica (Trial 1) were 
compared to serum samples collected pre-infection (Fig. 2). For all the 
cathepsin L and B peptidases tested, antibody-specific responses could 
be detected at three wpi. The highest responses were observed for 
rFhCL1 and rFhCL3, which were not statistically different from each 
other but were greater compared to values obtained for rFhCB3 and 
rFhCL2 (P < 0.001). OD values obtained at 16 wpi were higher than at 
three wpi for all three cathepsin L proteases (Fig. 2). By contrast, no 
change was observed for the level of anti-rFhCB3 antibodies at 16 wpi 
compared to three wpi, and these were statistically lower than those 
observed for the three anti-cathepsin L antibodies (P < 0.001). 
Fig. 1. Purification of recombinant cathepsin peptidases. SDS-PAGE anal-
ysis of the yeast-expressed recombinant Fasciola hepatica cathepsin L1 (rFhCL1; 
lane 1), cathepsin L2 (rFhCL2; lane 2), cathepsin L3 (rFhCL3; lane 3) and 
cathepsin B3 (rFhCB3; lane 4). M, molecular size markers. 
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3.2. Early detection of immune responses to F. hepatica using 
recombinant cathepsin cysteine peptidases 
Using sera obtained from sheep infected for 2, 9 and 18 days (Trial 2) 
each protease was assessed for their ability to detect liver fluke infection 
prior to three-weeks post infection (Fig. 3). For all the four recombinant 
antigens, antibody responses above the baseline level pre-infection 
could only be detected at 18 dpi. Although the highest antibody 
response detected at 18 dpi appeared to be against rFhCL3, this was not 
statistically significant compared with the other recombinant antigens 
because of the high variability between the six animals used per time 
point (P = 0.6581). 
Therefore, to further probe the utility of the various cathepsin 
cysteine peptidases to detect F. hepatica infection in sheep at three wpi, 
and to examine inter-individual variability of the cathepsin based ELISA, 
serum samples collected at this time point from 59 sheep (these animals 
were part of four separate experimental trials; Trials 1, 3, 4 and 5) were 
analysed (Fig. 4A). Elevated antibody responses were observed using 
rFhCL1 and rFhCL3 when compared to serum collected pre-infection (P 
< 0.001). rFhCL3 was the best antigen recognising IgG in serum sam-
ples, with a mean OD450 of 1.91, followed by rFhCL1 as the second best 
antigen with an OD450 of 1.46. Antibody responses at three wpi to the 
recombinant antigens rFhCL2 and rFhCB3 were also elevated but not to 
the same extent as the responses observed against rFhCL1 and rFhCL3 
that were significantly higher in comparison (P < 0.001). Ultimately, we 
found that the detection rate for the 59 animals evaluated at three wpi 
was 91 % (rFhCL1), 40 % (rFhCL2), 95 % (rFhCL3) and 41 % (rFhCB3). 
The animals used in these experimental infections were male and 
female of two different breeds (Dorset cross and Texel cross). Further-
more, two different F. hepatica isolates (South Gloucester and Italian 
isolates) were used for infections depending on the trial. However, we 
did not observe any correlations between these variables and antibody 
levels. A wide range of adult flukes (12–142) were recovered at necropsy 
(16 wpi), although the animals received an experimental dose of 120 or 
150 metacercariae depending on the trial. Analysis of the antibody re-
sponses at three wpi to all three cathepsin L recombinant peptidases 
showed a low but significant positive correlation with the number of 
flukes observed at necropsy (rFhCL1: r = 0.4220, P = 0.002; rFhCL2: r =
0.3473, P = 0.011; rFhCL3: r = 0.3749, P = 0.006) (Fig. 4B). By contrast, 
no correlation was found with rFhCB3 (r = 0.2134, P = 0.125) (data not 
shown). 
3.3. Assessment of anti-cathepsin peptidase antibody responses in 
naturally-infected lambs 
The efficacy and sensitivity of the recombinant cathepsin protease- 
based ELISA were evaluated using samples from 20 lambs naturally 
exposed to F. hepatica-contaminated pastures for eight weeks and then 
brought in-doors for a further seven weeks (Trial 6). F. hepatica infection 
in these animals was verified by FEC, coproantigen ELISA and by 
enumerating total adult flukes in livers at necropsy, which identified a 
total of eight infected animals (Table 1). Only seven sheep were positive 
for F. hepatica infection on the basis of the detection of parasite eggs 
within the faecal samples and/or within the gall bladder at necropsy. 
Adult liver flukes were recovered from three of these egg positive ani-
mals but the parasite burden was extremely low (one to three adult 
parasites). In addition, adult flukes (n = 2) were also recovered from an 
animal where no eggs were detected in the faeces. Of the eight infected 
animals, six were positive based on the coproantigen ELISA at 13 wpe. 
Antibody responses to the four cathepsin cysteine peptidases deter-
mined by ELISA in the serum of all 20 animals at 0, 4, 9 and 15 wpe are 
shown in Fig. 5. A cut-off point was determined as the mean optical 
density plus 3.09 standard deviations (SD) of the negative animals at 4 
wpe based on the parasitological data (dotted line in Fig. 5). This time 
point, rather than time 0, was chosen for the cut-off calculation to take 
into account the likelihood of animals being exposed to infections other 
than liver fluke (e.g. nematode parasites) which could affect the baseline 
antibody concentration in serum. 
Of the four recombinant cathepsin cysteine peptidases employed, the 
rFhCL1-ELISA could reliably distinguish between non-infected and 
infected sheep at both 9 and 15 wpe based on the cut-off value calcu-
lated above. This ELISA corroborated our parasitological data by iden-
tifying all eight infected animals amongst the 20 sheep (Fig. 5A). 
Moreover, the rFhCL1-ELISA identified one further infected animal that 
had no parasite eggs nor adult flukes at time of necropsy and, therefore, 
we speculate that it represents a recent infection. One of the confirmed 
infected sheep was detected as early as 4 wpe (Fig. 5A; Table 1). The 
rFhCL2 and rFhCL3-ELISA identified eight (100 %) and seven (88 %) of 
the infected animals, respectively, predominately at 15 wpe but the 
discrimination between infected and non-infected animals was less clear 
with these assays (Fig. 5B and C). The rFhCB3 was the least effective at 
determining antibodies in the serum of naturally-infected sheep and did 
not reliably distinguish infected from non-infected lambs (Fig. 5D). 
The results of the rFhCL1-ELISA were compared with the cop-
roantigen ELISA and FEC (Table 1). Unlike the ELISA assay, neither of 
these faecal assays detected any infected animals at 9 wpe; however, the 
coproantigen ELISA and FEC method identified infected animals in our 
cohort beginning from 11 wpe and 13 wpe, respectively. 
Fig. 2. Antibody responses to the Fasciola hepatica recombinant cathepsin 
peptidases. Mean optical density values for total IgG antibodies to the four 
recombinant cathepsin peptidases (rFhCL1, rFhCL2, rFhCL3 and rFhCB3) dur-
ing an experimental infection trial of 16 weeks (n = 7; mean ± standard de-
viation is represented). Statistical differences highlighted as follows: a. FhCL1 & 
FhCL2, P < 0.001; b. FhCL1 & FhCL2, P < 0.01; c. FhCL1 & FhCB3, P < 0.001; 
d. FhCL2 & FhCL3, P < 0.001; e. FhCL2 & FhCB3, P < 0.001; f. FhCL3 & FhCB3, 
P < 0.001. 
Fig. 3. Early detection of anti-cathepsin antibodies. Optical density values 
for total IgG antibodies to the four recombinant cathepsin peptidases (rFhCL1, 
rFhCL2, rFhCL3 and rFhCB3) were compared across three groups of six animals 
infected for 2, 9 and 18 days. Serological analysis was carried out before 
(represented by the Pre 2, Pre 9 and Pre 18 dpi samples) and after infection 
(represented by 2, 9 and 18 dpi samples). Error bars represent ± stan-
dard deviation. 
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3.4. Analysis of the effect of anthelmintic treatment on serological 
responses to the recombinant cathepsin cysteine peptidases 
Seropositivity of experimentally infected animals pre- and post- 
treatment with the flukicide, TCBZ, was assessed based on eleven ani-
mals, six of which were administered one dose of TCBZ at 17 wpi. 
Successful drug treatment of these sheep was verified by faecal egg 
counts 10 days after treatment (Trial 4). Pre-TCBZ treatment the FEC 
was 58 ± 18.9 eggs/gram, which post-TCBZ treatment was reduced to 
1.67 ± 2.88 eggs/gram. By 20 wpi, no eggs were recovered from the 
TCBZ-treated group. 
Antibody responses were monitored throughout infection and after 
drug treatment. All sheep displayed increasing antibodies responses to 
rFhCL1, rFhCL2 and rFhCL3 during the course of infection until 15 wpi 
(Fig. 6; Supplementary Fig. 1). As previously shown, sheep exhibited a 
much lower response to rFhCB3, and this peaked between seven and 11 
wpi before steadily declining over the following 14 weeks (Fig. 6D). 
Following administration of TCBZ all six animals in the treatment group 
exhibited a sharp decline in anti-rFhCL1, anti-rFhCL2 and anti-rFhCL3 
antibodies over the subsequent eight weeks and reached levels compa-
rable to those observed between three and seven wpi (Fig. 6). Statistical 
differences between the anti-rFhCL2 responses of the TCBZ-treated and 
non-treated animals were observed from 21 wpi (Fig. 6B; P < 0.05 - P <
0.001), whereas the decline in the anti-rFhCL1 and anti-rFhCL3 re-
sponses was more gradual, with significant differences only observed 
from 23 wpi (rFhCL3; P < 0.01 - P < 0.001; Fig. 6C) and 24 wpi (rFhCL1; 
P < 0.01 - P < 0.001; Fig. 6A). Analysis of the percentage reduction in 
the ELISA OD values pre- and post-drug treatment revealed that inde-
pendent of specific cathepsin peptidase used for the ELISA, by 25 wpi all 
the OD values were decreased following TCBZ treatment, with a mean 
reduction between 44.9–65.5 % (Supplementary Table 1). By contrast, 
the control untreated group displayed stable antibody levels in all three 
recombinant cathepsin L ELISA, and these did not vary from 15 wpi to 
25 wpi (Fig. 6). 
4. Discussion 
During the migration of F. hepatica through the organs of its 
mammalian host, the parasite secretes copious amounts of hydrolytic 
enzymes, most notably the cysteine peptidases cathepsin B and 
cathepsin L, which facilitates the destruction of tissue and formation of a 
migratory path. The expression and secretion of these peptidases are 
strictly regulated during development such that the newly excysted ju-
venile (NEJ) that penetrates the intestine primarily produces the 
Fig. 4. Analysis of antibody responses to 
cathepsin peptidases at 3 weeks post-infec-
tion. (A) Comparison of the optical density 
values for total IgG antibodies to the four re-
combinant cathepsin peptidases (rFhCL1, 
rFhCL2, rFhCL3 and rFhCB3) prior to infection 
(0 wpi) and 3 weeks later (3 wpi). Antibody 
responses statistically different at 3 wpi 
compared to the start of the experiment are 
shown (*** P < 0.001). Error bars represent ±
standard deviation. (B) Scatter plot and 
Spearman correlation coefficient of total adult 
fluke count at necropsy and the optical density 
values for total IgG anti-rFhCL1, anti-rFhCL2 
and anti-rFhCL3 antibodies.   
Table 1 
Comparative analyses of the three diagnostic methods for fasciolosis at three time points following exposure to naturally infected pastures (weeks post exposure, wpe); 
serological rFhCL1-ELISA (ELISA), faecal egg count (FEC) and copro-antigen ELISA (Copro). Positive result shown by shaded X or by the number of eggs/gram.  
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isoforms cathepsin B1, B2 and B3 and cathepsin L3 and L4 (Cwiklinski 
et al., 2018). However, as the parasite migrates through the liver pa-
renchyma, the secretion of these peptidases decline while the synthesis 
and secretion of isoforms cathepsin L1 and L2 increase (Cwiklinski et al., 
2021). Moreover, within the bile ducts the mature parasites predomi-
nantly secretes cathepsin L1, while the expression of cathepsin L2 and L5 
are less dominant (Collins et al., 2004; Robinson et al., 2008; Cwiklinski 
et al., 2019). The cathepsins B and cathepsins L peptidase families share 
only ~27 % identity and no cross reactivity was observed between them. 
However, members within each family exhibit high structural similarity 
(ranging between 72–80% identity) and therefore they exhibit 
immunological cross-reactivity (Law et al., 2003; Garza-Cuartero et al., 
2018; Cwiklinski et al., 2019). This, and the timely and large expression 
of the various cathepsin B and cathepsin L peptidases, imply that they 
represent good candidates for developing immunodiagnostics assays 
which depend on the detection of parasite-specific antibody responses in 
the serum of infected animals. 
Given the differences between the cathepsin cysteine peptidases and 
their differential expression during the parasites migratory life cycle, an 
objective of this study was to compare the performance of four different 
enzymes, which we have shown by proteomic studies to be predomi-
nantly excreted/secreted by NEJ (FhCL3 and FhCB3) and immature/ 
Fig. 5. Detection of total IgG in serum sam-
ples of naturally infected sheep after first 
exposure to Fasciola hepatica. Using four re-
combinant antigens (rFhCL1, rFhCl2, rFhCL3 
and rFhCB3), total IgG (quantified as optical 
density) was detected by serum ELISA in sam-
ples taken before and at three time points after 
first exposure to F. hepatica. Data represented as 
mean ± standard deviation. The cut-off point, 
based on the mean optical density plus 3.09 
times the standard deviation (SD) of the nega-
tive animals at 4 wpe, is shown by the dotted 
line.   
Fig. 6. Analysis of seropositivity pre- and 
post- triclabendazole treatment. Mean opti-
cal density values for total IgG antibodies to 
four recombinant cathepsin peptidases, (A) 
rFhCL1, (B) rFhCL2, (C) rFhCL3 and (D) rFhCB3 
during an experimental infection trial of 25 
weeks. Eleven animals were separated into two 
groups, (1) Untreated, control Fasciola hepatica 
infected group (n = 5) and (2) Triclabendazole 
(TCBZ) treated group (n = 6). The dotted line 
represents 17 wpi when TCBZ treatment was 
given. Data represented as mean ± standard 
deviation. Statistical differences observed be-
tween the untreated and treated groups are 
shown (* P < 0.05, ** P < 0.01, *** P < 0.001).   
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adult parasites (FhCL1, FhCL2), in a diagnostic ELISA for fasciolosis. The 
four parasite enzymes were produced as recombinant proteins in the 
methylotrophic yeast P. pastoris using protocols that we have previously 
described for the production of recombinant F. hepatica cathepsin L1 
(Collins et al., 2004). In this system the recombinant proteins are 
secreted into the yeast culture medium and each can be readily isolated 
in the same manner by Nickle-chelate affinity chromatography. This 
provided ample quantities of high quality, properly folded (as judged by 
functional enzymatic activity) products of ~37 kDa that represent the 
stable zymogenic form of the enzymes. ELISA assays with low back-
ground (OD < 0.1) were developed for each antigen using 100 ng pro-
tein per well that was used to screen serum from sheep (at 1/100 
dilution). 
It was immediately clear from our studies that all cathepsin L pep-
tidases, FhCL1, FhCL2 and FhCL3 performed better in the ELISA when 
compared to the cathepsin B3. This is perhaps not surprising given that 
the cathepsin B enzymes are produced by the NEJ stages, mainly during 
their passage through the intestine wall, and their expression is gradu-
ally switched off over the first three to four weeks of parasite develop-
ment (Cwiklinski et al., 2018, 2021). The immune responses in 
experimentally-infected sheep correlated with this molecular off-switch 
since we observed that antibodies to cathepsin B3 gradually increased 
following infection to approximately seven weeks post-infection, after 
which they steadily declined over the course of the infection (see Fig. 6). 
By contrast, the antibody responses to the cathepsin L peptidases 
increased rapidly in early infection, surpassing those of cathepsin B 
within the first four weeks, and continued to escalate until week 15 
when they remained high during the course of the 25-week infection. 
The continued increase of antibodies was helped, no doubt, by the 
re-stimulation and expansion of B-cells responsive to epitopes that are 
shared by the enzymes as their predominance in the secretome switches 
from FhCL3 to FhCL2 to FhCL1 as the parasite develops. 
Amongst the cathepsin L peptidases, FhCL3 and FhCL1 consistently 
performed better than FhCL2 at the early stages of experimental infec-
tion although no significant difference could be observed between the 
three enzymes at the latter stages of infection. While FhCL3 elicited the 
strongest antibody response in the first three weeks of infection, this was 
not significantly different from the antibody response recognising FhCL1 
due to the high variability of responses. As infection develops, expand-
ing B-cell responses would tend to be directed against shared cathepsin L 
epitopes rather than unique regions and thus the type of cathepsin L 
used in the ELISA became less discriminating. On the other hand, 
reflective of the relatively low antibody responses elicited to FhCB3, this 
antigen showed a sensitivity of approximately 70 % between seven and 
11 weeks after infection but was not reliable after 20 weeks post- 
infection when titres had declined to background levels. 
Because F. hepatica causes extensive tissue pathology and haemor-
rhaging during the migration of the immature flukes through the liver 
parenchyma, with the consequential animal production losses, it is 
important that diagnostic tests pick up infections as early as possible so 
that control interventions can be made quickly. We found that the 
earliest time point at which antibodies could be detected in 
experimentally-infected sheep using our ELISA was at 18 days post 
infection when either rFhCL3 or rFhCL1 were employed as the detecting 
antigen, albeit at this time point, diagnosis was not consistent due to the 
very high variability of antibody responses between animals. However, 
the detection was more robust at three weeks post-infection (21–22 dpi) 
with 91 % of the 59 infected animals tested at this time point deemed 
positive by the rFhCL1-ELISA and 95 % by the rFhCL3-ELISA. Interest-
ingly, a low but significant relationship was observed between the 
antibody readings obtained at the three-week time point and the number 
of flukes recovered at necropsy 13 weeks later (16 weeks post-infection) 
which suggested, unsurprisingly perhaps, that there was a correlation 
between greater fluke burden and higher titres early IgG antibodies soon 
after infection. From seven weeks post-infection, all three cathepsins L 
assays detected fasciolosis in sheep with 100 % sensitivity. The time of 
seroconversion and the extent of antibody induced did not appear to be 
influenced by the sex or breed of the sheep, nor by the strain of parasite 
used for infection, albeit this is something that needs to be investigated 
with even greater animal numbers. 
To evaluate if our ELISA could detect fasciolosis in naturally-infected 
animals, 20 lambs were exposed to pastures contaminated with liver 
fluke metacercariae for eight weeks before housing for a further seven 
weeks. ELISA were performed on serum samples taken at 0, 4, 9 and 15 
wpe. Overall, we found that rFhCL1 and rFhCL3 were again the best 
performing antigens in our ELISA, and exhibited a similar pattern of 
antibody responses to what was observed in experimental infection. 
However, in the case of natural infection, the IgG levels were lower 
(overall highest average OD450 of 0.65 for rFhCL1 at nine wpe, 
compared with an overall maximum OD > 2.0 for the same antigen in 
animals experimentally infected in Trial 1). This was not unexpected 
given that only eight of the field-exposed animals became infected, and 
these harboured very low sub-clinical parasite burdens; at necropsy no 
more than three adult flukes were recovered from any of the infected 
animals. Encouragingly, all animals that were infected, regardless of the 
low parasite burden, were detected by the rFhCL1-ELISA by nine weeks 
after exposure and one animal was deemed positive after four weeks of 
field exposure. 
Our data is consistent with that of Martínez-Sernández et al. (2018) 
who found that FhCL1, FhCL2 and FhCL5 exhibited 100 % sensitivity in 
assessing chronic infection in naturally infected sheep and cattle, 
although they did observe that FhCL2 exhibited a greater sensitivity in 
detecting fasciolosis in cattle. The recombinant proteins employed by 
Martínez-Sernández et al. (2018) were produced as insoluble proteins in 
the prokaryotic system, Escherichia coli, before being subjected to a 
re-folding process that resulted in antigens that performed similarly to 
the peptidases produced by us. In addition, the studies by Kuerpick et al. 
(2013) and Walsh et al. (2021) show that recombinant FhCL1 expressed 
in yeast (using similar methods as described here) effectively detected 
F. hepatica experimental infections in sheep and cattle as early as four 
weeks after infection. However, Walsh et al. (2021) suggested that 
reactivity to recombinant FhCL1 in naturally-infected animals was 
weaker and more variable than the one observed in experimentally 
infected animals. 
The rFhCL1-ELISA was compared to two standard methods of diag-
nosis, FEC and coproantigen-ELISA. FEC has been used for many years 
for fasciolosis detection although it is time consuming, labour intensive 
and dependent on the consistency of egg shedding in faeces. The original 
version of the coproantigen-ELISA kit, based on the work of Mezo et al. 
(2004), had some described problems regarding sensitivity due to fluc-
tuation in coproantigen levels (Valero et al., 2009; Novobilský et al., 
2012), but this issue was overcome by introducing a combination of 
biotinylated secondary antibody and a peroxidase-labelled streptavidin 
for detection (Martínez-Sernández et al., 2016). Despite these advances, 
the method is still limited in detecting disease in animals before flukes 
have matured in the bile ducts and when animals are infected with low 
fluke burdens (George et al., 2017, 2019). While seven of the eight 
field-exposed sheep that picked up infection in our study were detected 
by the rFhCL1-ELISA at nine wpe, neither FEC nor the coproantigen 
ELISA test deemed these as positive at this time point. However, at 15 
wpe all three tests were comparable, with the exception of one animal 
(no. 4, Table 1) that was not positive by coproantigen ELISA, and 
another animal (no. 5, Table 1), which was positive by rFhCL1-ELISA at 
15 wpe but not positive by FEC or coproantigen ELISA and was, there-
fore, likely infected with immature flukes. The corollary of these find-
ings are that the rFhCL-ELISA can detect subclinical infections of as low 
as one to three flukes in sheep within the first nine weeks of infection 
and as early as three weeks, for sheep with higher fluke burdens. 
Finally, the antibody responses of experimentally-infected sheep 
throughout the acute and chronic stages of the disease and following 
TCBZ treatment at 17 weeks after infection were examined. In non- 
treated animals the antibody responses to rFhCL1, rFhCL2 and rFhCL3 
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increased during the acute phase of infection and after peaking at about 
15 weeks post-infection, remained constant for the subsequent 10 
weeks. By contrast, antibody responses to all three peptidases declined 
rapidly in the animals administered TCBZ treatment, consistent with 
that observed by Munita et al. (2019a) in cattle using four commercially 
available ELISA kits. The data demonstrates that adult parasites residing 
in the bile ducts must continually stimulate the host adaptive immune 
systems, likely by way of their blood-feeding activity through the 
punctured bile duct and their regurgitation of secreted proteinases, and 
other antigens. Presumably, the delivery of an array of immunomodu-
latory molecules present in their digestive secretions (Ryan et al., 2020) 
into the host bloodstream maintains an immuno-suppressive or regula-
tory control that provides a benefit to the parasite, despite its location in 
what is perceived to be an immunologically-protected site (Farina et al., 
2009). Of greater importance to the health of the infected animal would 
be the possibility that continued suppression of immune responses 
would make them more susceptible to co-infections with microbes (e.g. 
tuberculosis) or other parasites (e.g. rumen fluke) (Cwiklinski et al., 
2016; Howell et al., 2019; Munita et al., 2019b). While drug efficacy is 
best monitored using FEC reduction tests, which can provide definitive 
assessments within two weeks of treatment, the observed correlation 
between clearance of the parasites and decline of antibodies suggest the 
possibility of using the rFhCL-ELISA as an additional assay to monitor 
the success of drug treatments by comparing antibody responses before 
and after treatment. 
5. Conclusion 
Since our first characterisation of the cathepsin L family, many lab-
oratories have exploited these enzymes in the development and com-
mercialisation of diagnostic tests for detecting fasciolosis in sheep, cattle 
(Carnevale et al., 2001; Selemetas et al., 2014; Bloemhoff et al., 2015; 
Munita et al., 2016; Mokhtarian et al., 2018) and humans (O’Neill et al., 
1998; Gonzales Santana et al., 2013; Gottstein et al., 2014). These an-
tigens are amongst the most immunogenic molecules secreted by the 
parasite and different isoforms are produced from the moment parasites 
excyst in the duodenum to their long-term residence in the bile ducts. 
Although, all tested isoforms of the cathepsins L perform with 100 % 
sensitivity for the detection of sheep fasciolosis after seven weeks of 
infection, rFhCL1 and rFhCL3 showed a slightly better performance than 
rFhCL2, particularly in the acute stages of disease. The reason for this 
difference is unclear but could be related to the relative abundance at 
which each enzyme is secreted by the parasite, the amount of 
cross-reactive epitopes, and the affinity of specific epitopes for specific 
B-cell receptors. Antibodies measured in the rFhCL-ELISA were shown to 
remain high throughout a chronic infection but decline after drug 
treatment with the flukicide, TCBZ, implying that the test could be 
adapted to trace the effectiveness of drug treatment. Cathepsin B3 may 
not be as useful for the serological diagnosis of fasciolosis because of the 
low levels of antibodies elicited and their decline from seven weeks 
post-infection, although it could prove to be a useful marker of acute 
infection. 
A number of methods to diagnose fasciolosis in livestock have been 
described (reviewed by Alvarez Rojas et al., 2014), for example FEC 
(Graham-Brown et al., 2019; Kamaludeen et al., 2019), 
coproantigen-ELISA (Martínez-Sernández et al., 2016), serum-ELISA 
(Cornelissen et al., 1999, 2001; Salimi-Bejestani et al., 2005; Mezo 
et al., 2007; Sugiyama et al., 2021; Walsh et al., 2021), PCR 
(Robles-Pérez et al., 2013; Calvani et al., 2018; Shi et al., 2020) or LAMP 
techniques (loop-mediated isothermal amplification; Martínez-Valla-
dares and Rojo-Vázquez, 2016) but only serum-ELISA, PCR and LAMP 
have demonstrated an ability to diagnose early acute stages of infection 
(Martínez-Pérez et al., 2012; Mazeri et al., 2016). The rFhCL-ELISA 
developed here were very effective assays in detecting subclinical liver 
fluke in lambs exposed to natural infection on pastures. Testing of lambs 
each year as sentinel animals would be a rapid and straightforward way 
to assess the extent of infection on sheep farms during various seasons 
and annually, which is also important for understanding the prevalence 
of F. hepatica in cattle in areas where sheep and cattle co-graze. By taking 
a ‘test and treat’ approach to disease management farmers would save 
time and money which would lessen the prospect of drug resistant 
parasites emerging and reduce the environmental contamination of 
pastures with chemical treatments. 
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